SHANGHAI--(BUSINESS WIRE)--EpimAb Biotherapeutics, an emerging Shanghai-based biopharmaceutical company specializing in bispecific antibodies, today announced the appointment of Dr. Xinyi “David” Gu ...
Merrill’s Merry Men Raked In $209 Million in 2008Which, if you think about it, is only a fraction of the $27.6 billion the firm lost … hmmm, no, there’s no good way to look at this.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results